TY - JOUR
T1 - Molecular forms of atrial natriuretic peptides in dog atrium and plasma
AU - Cernacek, P.
AU - Maher, E.
AU - Crawhall, J. C.
AU - Levy, M.
N1 - Funding Information:
The authors acknowledge technical assistance by H. Champagne and P. Smolen. This work was supported by grants from Medical Research Council of Canada (VT-35271 to M.L. and from Department of Medicine, McGill University to P.C.
PY - 1988
Y1 - 1988
N2 - The level of immunoreactive ANP (iANP) as determined by radioimmunoassay, exhibits a fairly even distribution throughout the canine atria. However, the maximal concentration was found in the appendages of both the left and right atrium, and the level was significantly higher on the left side in all analyzed localizations. Reverse-phase HPLC of atrial extracts, coupled with RIA, revealed the presence of three iANP fractions. The dominant fraction (65% of iANP) has an estimated molecular weight 16,300, showing that it corresponds to the hormone precursor. By contrast, in the plasma extract, 92% of iANP coelutes with synthetic human ANP99-126, thus confirming the structural identity of dog and human ANP.
AB - The level of immunoreactive ANP (iANP) as determined by radioimmunoassay, exhibits a fairly even distribution throughout the canine atria. However, the maximal concentration was found in the appendages of both the left and right atrium, and the level was significantly higher on the left side in all analyzed localizations. Reverse-phase HPLC of atrial extracts, coupled with RIA, revealed the presence of three iANP fractions. The dominant fraction (65% of iANP) has an estimated molecular weight 16,300, showing that it corresponds to the hormone precursor. By contrast, in the plasma extract, 92% of iANP coelutes with synthetic human ANP99-126, thus confirming the structural identity of dog and human ANP.
UR - http://www.scopus.com/inward/record.url?scp=0023943961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023943961&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(88)90353-0
DO - 10.1016/0024-3205(88)90353-0
M3 - Article
C2 - 2967414
AN - SCOPUS:0023943961
SN - 0024-3205
VL - 42
SP - 2533
EP - 2539
JO - Life Sciences
JF - Life Sciences
IS - 24
ER -